Amniotic membrane patch shows promise for stubborn diabetic wounds
NCT ID NCT06565156
First seen Feb 01, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This study tests whether adding a special amniotic membrane graft (BR-AM) to standard wound care helps heal diabetic foot ulcers better than standard care alone. About 72 adults with non-infected, non-healing ulcers will be randomly assigned to receive either BR-AM plus standard care or standard care only. The main goal is to see if more wounds close completely within 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site 01
Vista, California, 92081, United States
-
Site 02
San Francisco, California, 94115, United States
-
Site 15
Chapel Hill, North Carolina, 27599, United States
-
Site 16
Lake Success, New York, 11042, United States
-
Site 17
Guntersville, Alabama, 35976, United States
-
Site 18
Boston, Massachusetts, 02118, United States
-
Site 19
Palmdale, California, 93551, United States
-
Site 20
Deerfield Beach, Florida, 33442, United States
-
Site 21
Burleson, Texas, 76028, United States
-
Site 22
Mesa, Arizona, 85206, United States
-
Site 23
Springfield, Illinois, 62704, United States
-
Site 24
San Antonio, Texas, 78229, United States
-
Site 25
Tucson, Arizona, 85723, United States
-
Site 26
Detroit, Michigan, 48201, United States
-
Site 27
Coral Gables, Florida, 33134, United States
-
Site 28
DeLand, Florida, 32720, United States
-
Site 29
Brownsville, Texas, 78520, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BR-AM (amniotic membrane allograft)
What this could lead to
If successful, this could provide a new treatment option to help heal diabetic foot ulcers faster and reduce complications.
What could go wrong
This is a small, early-stage trial with only 72 participants. The treatment may not prove more effective than standard care, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.